Events in 2022

A day spent looking at genomics and their role in clinical microbiology. The focus of this meeting is on the latest genomic trends that are currently becoming available in the field of clinical microbiology. The opportunity to listen to leading experts and the latest opinions on current genomic development.
The chance to interact with commercial companies and see the latest technology available on the market.

Haematology and Trauma Group Webinar
Trauma and Coagulopathy

This course is aimed at Biomedical Scientists preparing for their specialist portfolios and working in histopathology departments involved in the preparation of routine histological sections.
The course may also be useful for support staff involved in section preparation and quality control.
The course aims to teach recognition of a range of tissues and how knowing these can impact on patient quality. The afternoon session will aim to link what has been learned to consequences for the lab and patient management.

An Abbott representative will give an overview of the Abbott laboratory processes.

On completion of this webinar students will have a basic knowledge of Principles of immunofluorescence, Optimal specimen preparation for DIF, Practical aspects of cryotomy and processing, DIF imaging considerations, Interpretation of DIF, Diagnostic implications of DIF findings.

Discussing the staining applications and principles employed to classify and demonstrate lipids, common infective agents, pigments and minerals.

A daylong short course aimed at current or prospective trainers in diagnostic laboratories.

56th BSMM Annual Scientific Meeting – containing a mix of clinical and basic science papers on medical mycology

As genomic testing becomes more routine for cellpath labs, there is an increased need for
assessment of the tumour content for the more complex tests in particular, in order to ensure
there is enough tumour material to ensure the test result is valid.

Tumour tissue however is mixed, usually containing both tumour and non-tumour cells. Tumours
are also heterogenous, with some areas more relevant for a given test than others. For this
reason, the region of tumour that the DNA/ RNA is extracted from must be assessed to ensure it is
suitable and contains a sufficient amount of tumour cells for genomic analysis.

This course has been developed for histopathologists, clinical scientists and biomedical scientists
involved in the selection of tumour samples for genomic testing.

“From sectioning to interpretation”, a simple overview of the basic ICC processes.